PT Novapharin (Indonesia)

Novapharin is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Jawa Timur. The company was founded in 1987. Novapharin was founded by Dr. Arif Santoso and Dr. Rina Wijaya, who envisioned creating a leading pharmaceutical company in Indonesia. The company focuses on the development and manufacturing of a wide range of pharmaceutical products, including over-the-counter medications, prescription drugs, and specialized healthcare solutions. Novapharin's primary business line is pharmaceutical manufacturing, with a secondary focus on research and development of innovative healthcare products. The company operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Bandung. Some of the main product types offered by Novapharin include antibiotics, pain relievers, and cardiovascular medications. The company has developed well-known brands such as Novacare and Pharinex, which are widely recognized in the Indonesian market. Novapharin has expanded its operations beyond Indonesia, establishing a presence in several Southeast Asian countries, including Malaysia, Thailand, and Vietnam. The company is actively exploring opportunities to enter new markets in the Asia-Pacific region. In collaboration with international pharmaceutical companies, Novapharin has formed strategic partnerships to enhance its research capabilities and product offerings. The company is a member of the Indonesian Pharmaceutical Association and participates in various industry forums to stay at the forefront of pharmaceutical advancements. Novapharin is committed to improving healthcare outcomes through innovation and quality. The company's mission is to provide accessible and affordable healthcare solutions to communities, with a vision to become a leading pharmaceutical company in the Asia-Pacific region.